Share Price and Basic Stock Data
Last Updated: November 22, 2025, 8:18 am
| PEG Ratio | 12.46 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cyient Ltd operates in the IT Consulting and Software sector, with a current market price of ₹1,153 and a market capitalization of ₹12,810 Cr. The company reported a significant increase in sales, rising from ₹4,534 Cr in FY 2022 to ₹6,016 Cr in FY 2023, and is projected to reach ₹7,360 Cr in FY 2025. The quarterly sales figures indicate a consistent upward trend, with ₹1,250 Cr in June 2022 and increasing to ₹1,861 Cr by March 2024. This growth trajectory reflects a robust demand for Cyient’s services, particularly in engineering and digital transformation solutions. The operating profit margin (OPM) stood at 15% for FY 2025, showcasing operational efficiency amidst rising revenues. The increase in sales is complemented by a growing number of shareholders, which reached 2,12,929 by September 2025, reflecting an expanding investor interest in the firm.
Profitability and Efficiency Metrics
Cyient Ltd’s profitability metrics highlight its operational strengths, with a net profit of ₹614 Cr for FY 2025 and a return on equity (ROE) of 12.8%. The operating profit showed a steady increase from ₹1,003 Cr in FY 2023 to ₹1,138 Cr in FY 2025. The company’s operating profit margin (OPM) was reported at 15% for FY 2025, indicating stable profitability despite fluctuating expenses. The interest coverage ratio (ICR) was an impressive 13.36x, suggesting that the company comfortably meets its interest obligations, enhancing overall financial stability. However, the cash conversion cycle (CCC) stood at 128 days, which may indicate potential inefficiencies in working capital management compared to sector norms. Furthermore, the net profit margin for FY 2025 was recorded at 8.87%, which, while respectable, is slightly lower than the average margins typically seen in the IT consulting space.
Balance Sheet Strength and Financial Ratios
Cyient’s balance sheet reveals a solid financial foundation with total assets amounting to ₹7,621 Cr and total borrowings of ₹436 Cr, resulting in a low total debt-to-equity ratio of 0.04. This indicates prudent financial management and minimal reliance on debt financing. The company’s reserves have grown significantly, reaching ₹5,509 Cr in September 2025, which strengthens its equity base and provides a buffer for future investments or downturns. The price-to-book value (P/BV) ratio stood at 2.64x, reflecting strong growth expectations relative to its book value. Additionally, the return on capital employed (ROCE) was reported at 16.6%, demonstrating effective utilization of capital in generating profits. However, the current ratio of 3.03x suggests a comfortable liquidity position, yet it should be monitored to ensure it aligns with operational needs without excess idle cash.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cyient Ltd illustrates a well-diversified ownership structure. As of September 2025, promoters hold 23.28% of the shares, while foreign institutional investors (FIIs) decreased their stake to 17.56%. Domestic institutional investors (DIIs) have increased their holdings to 38.42%, indicating strong local investor confidence. The public shareholding stood at 20.11%, reflecting a healthy retail investor interest. The number of shareholders surged from 1,22,852 in December 2022 to 2,12,929 by September 2025, suggesting a growing appeal of the company in the market. However, the decline in FIIs could raise concerns about international investor sentiment, which may impact stock performance. Overall, the diverse shareholding pattern could provide stability against market volatility, promoting long-term growth.
Outlook, Risks, and Final Insight
Looking ahead, Cyient Ltd’s growth potential appears promising due to its strong revenue trajectory and solid balance sheet. However, challenges remain, including the high cash conversion cycle of 128 days, which could hinder operational efficiency and cash flow. Additionally, fluctuations in international markets may impact FIIs’ confidence and investment levels. Risks associated with currency fluctuations and competition from other IT service providers must also be considered. Nonetheless, the company’s robust financial metrics, including a high interest coverage ratio and growing reserves, provide a cushion against potential downturns. If Cyient can effectively manage its working capital and maintain profitability, it could continue to attract both domestic and foreign investors, ensuring sustained growth in the competitive IT consulting landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Cyient Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Naapbooks Ltd | 156 Cr. | 145 | 194/99.8 | 23.9 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 26.5 Cr. | 207 | 310/140 | 18.9 | 26.7 | 0.48 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.29 Cr. | 1.08 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Globalspace Technologies Ltd | 57.5 Cr. | 16.7 | 25.0/13.7 | 103 | 15.8 | 0.00 % | 2.13 % | 1.41 % | 10.0 |
| First Fintec Ltd | 7.09 Cr. | 6.82 | 11.7/5.25 | 88.6 | 10.3 | 0.00 % | 0.28 % | 0.85 % | 10.0 |
| Industry Average | 19,958.08 Cr | 574.21 | 91.41 | 126.08 | 0.56% | 14.93% | 20.42% | 6.95 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,250 | 1,396 | 1,618 | 1,751 | 1,686 | 1,778 | 1,821 | 1,861 | 1,676 | 1,849 | 1,926 | 1,909 | 1,712 |
| Expenses | 1,057 | 1,192 | 1,335 | 1,429 | 1,371 | 1,453 | 1,495 | 1,526 | 1,411 | 1,552 | 1,648 | 1,611 | 1,484 |
| Operating Profit | 193 | 205 | 283 | 322 | 316 | 326 | 326 | 335 | 265 | 297 | 278 | 298 | 228 |
| OPM % | 15% | 15% | 18% | 18% | 19% | 18% | 18% | 18% | 16% | 16% | 14% | 16% | 13% |
| Other Income | 34 | -2 | 19 | -16 | -1 | 7 | -32 | 23 | 21 | 51 | -17 | 41 | 70 |
| Interest | 16 | 31 | 26 | 26 | 28 | 27 | 29 | 32 | 26 | 28 | 20 | 19 | 16 |
| Depreciation | 51 | 63 | 70 | 73 | 68 | 66 | 66 | 67 | 66 | 66 | 68 | 68 | 68 |
| Profit before tax | 160 | 108 | 206 | 208 | 219 | 240 | 200 | 259 | 195 | 254 | 174 | 252 | 214 |
| Tax % | 27% | 27% | 24% | 21% | 23% | 24% | 23% | 24% | 24% | 27% | 26% | 26% | 26% |
| Net Profit | 116 | 79 | 156 | 163 | 169 | 184 | 153 | 197 | 148 | 187 | 128 | 186 | 157 |
| EPS in Rs | 10.52 | 7.16 | 14.12 | 14.76 | 15.20 | 16.10 | 13.28 | 17.06 | 12.97 | 16.14 | 11.02 | 15.35 | 13.85 |
Last Updated: August 1, 2025, 10:25 pm
Below is a detailed analysis of the quarterly data for Cyient Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,712.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,909.00 Cr. (Mar 2025) to 1,712.00 Cr., marking a decrease of 197.00 Cr..
- For Expenses, as of Jun 2025, the value is 1,484.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,611.00 Cr. (Mar 2025) to 1,484.00 Cr., marking a decrease of 127.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 228.00 Cr.. The value appears to be declining and may need further review. It has decreased from 298.00 Cr. (Mar 2025) to 228.00 Cr., marking a decrease of 70.00 Cr..
- For OPM %, as of Jun 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 13.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Mar 2025) to 70.00 Cr., marking an increase of 29.00 Cr..
- For Interest, as of Jun 2025, the value is 16.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 68.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 68.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 214.00 Cr.. The value appears to be declining and may need further review. It has decreased from 252.00 Cr. (Mar 2025) to 214.00 Cr., marking a decrease of 38.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
- For Net Profit, as of Jun 2025, the value is 157.00 Cr.. The value appears to be declining and may need further review. It has decreased from 186.00 Cr. (Mar 2025) to 157.00 Cr., marking a decrease of 29.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.85. The value appears to be declining and may need further review. It has decreased from 15.35 (Mar 2025) to 13.85, marking a decrease of 1.50.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:31 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,206 | 2,736 | 3,094 | 3,586 | 3,914 | 4,618 | 4,427 | 4,132 | 4,534 | 6,016 | 7,147 | 7,360 | 7,328 |
| Expenses | 1,796 | 2,335 | 2,680 | 3,109 | 3,394 | 3,985 | 3,881 | 3,557 | 3,717 | 5,013 | 5,844 | 6,222 | 6,310 |
| Operating Profit | 410 | 401 | 414 | 477 | 520 | 633 | 546 | 575 | 818 | 1,003 | 1,303 | 1,138 | 1,019 |
| OPM % | 19% | 15% | 13% | 13% | 13% | 14% | 12% | 14% | 18% | 17% | 18% | 15% | 14% |
| Other Income | 17 | 122 | 112 | 79 | 147 | 131 | 158 | 140 | 112 | 35 | -2 | 97 | 165 |
| Interest | 1 | 6 | 16 | 17 | 20 | 33 | 49 | 43 | 39 | 100 | 116 | 93 | 72 |
| Depreciation | 72 | 71 | 89 | 95 | 105 | 111 | 188 | 194 | 192 | 257 | 267 | 267 | 276 |
| Profit before tax | 354 | 446 | 421 | 444 | 541 | 620 | 468 | 477 | 698 | 681 | 918 | 875 | 836 |
| Tax % | 29% | 25% | 24% | 24% | 26% | 23% | 27% | 24% | 25% | 24% | 23% | 26% | |
| Net Profit | 266 | 351 | 320 | 340 | 403 | 477 | 341 | 364 | 522 | 514 | 703 | 648 | 614 |
| EPS in Rs | 23.76 | 31.43 | 28.94 | 30.54 | 36.00 | 42.33 | 31.14 | 33.06 | 47.35 | 46.52 | 61.57 | 55.45 | 51.70 |
| Dividend Payout % | 21% | 25% | 24% | 34% | 36% | 35% | 48% | 51% | 51% | 56% | 49% | 47% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 31.95% | -8.83% | 6.25% | 18.53% | 18.36% | -28.51% | 6.74% | 43.41% | -1.53% | 36.77% | -7.82% |
| Change in YoY Net Profit Growth (%) | 0.00% | -40.79% | 15.08% | 12.28% | -0.17% | -46.87% | 35.26% | 36.66% | -44.94% | 38.30% | -44.59% |
Cyient Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 11% |
| 3 Years: | 18% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 12% |
| 3 Years: | 5% |
| TTM: | -10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 25% |
| 3 Years: | 12% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 2:25 am
Balance Sheet
Last Updated: November 9, 2025, 1:52 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 56 | 56 | 56 | 56 | 56 | 55 | 55 | 55 | 55 | 55 | 56 | 56 | 56 |
| Reserves | 1,532 | 1,788 | 1,774 | 2,061 | 2,288 | 2,509 | 2,506 | 2,902 | 3,061 | 3,411 | 4,203 | 5,254 | 5,509 |
| Borrowings | 6 | 147 | 214 | 211 | 283 | 368 | 711 | 577 | 573 | 1,218 | 788 | 513 | 436 |
| Other Liabilities | 356 | 582 | 668 | 798 | 773 | 927 | 870 | 940 | 1,072 | 1,815 | 1,883 | 1,798 | 1,922 |
| Total Liabilities | 1,950 | 2,574 | 2,713 | 3,126 | 3,400 | 3,860 | 4,142 | 4,475 | 4,762 | 6,500 | 6,928 | 7,621 | 7,922 |
| Fixed Assets | 337 | 789 | 657 | 751 | 798 | 978 | 1,305 | 1,361 | 1,345 | 2,825 | 2,826 | 2,929 | 3,063 |
| CWIP | 7 | 10 | 10 | 26 | 52 | 104 | 146 | 88 | 13 | 44 | 57 | 79 | 8 |
| Investments | 93 | 101 | 160 | 196 | 143 | 55 | 41 | 34 | 445 | 518 | 436 | 502 | 508 |
| Other Assets | 1,514 | 1,674 | 1,886 | 2,153 | 2,409 | 2,723 | 2,650 | 2,992 | 2,959 | 3,113 | 3,609 | 4,112 | 4,343 |
| Total Assets | 1,950 | 2,574 | 2,713 | 3,126 | 3,400 | 3,860 | 4,142 | 4,475 | 4,762 | 6,500 | 6,928 | 7,621 | 7,922 |
Below is a detailed analysis of the balance sheet data for Cyient Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 56.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 56.00 Cr..
- For Reserves, as of Sep 2025, the value is 5,509.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,254.00 Cr. (Mar 2025) to 5,509.00 Cr., marking an increase of 255.00 Cr..
- For Borrowings, as of Sep 2025, the value is 436.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 513.00 Cr. (Mar 2025) to 436.00 Cr., marking a decrease of 77.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,922.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,798.00 Cr. (Mar 2025) to 1,922.00 Cr., marking an increase of 124.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 7,922.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,621.00 Cr. (Mar 2025) to 7,922.00 Cr., marking an increase of 301.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,063.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,929.00 Cr. (Mar 2025) to 3,063.00 Cr., marking an increase of 134.00 Cr..
- For CWIP, as of Sep 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 71.00 Cr..
- For Investments, as of Sep 2025, the value is 508.00 Cr.. The value appears strong and on an upward trend. It has increased from 502.00 Cr. (Mar 2025) to 508.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4,343.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,112.00 Cr. (Mar 2025) to 4,343.00 Cr., marking an increase of 231.00 Cr..
- For Total Assets, as of Sep 2025, the value is 7,922.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,621.00 Cr. (Mar 2025) to 7,922.00 Cr., marking an increase of 301.00 Cr..
Notably, the Reserves (5,509.00 Cr.) exceed the Borrowings (436.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 404.00 | 254.00 | 200.00 | 266.00 | 237.00 | 265.00 | -165.00 | -2.00 | 245.00 | 0.00 | -787.00 | -512.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 79 | 71 | 72 | 66 | 64 | 64 | 60 | 71 | 59 | 68 | 64 | 70 |
| Inventory Days | 189 | 124 | 156 | 160 | 211 | 110 | 178 | 228 | 177 | 185 | ||
| Days Payable | 599 | 522 | 453 | 323 | 347 | 314 | 336 | 374 | 189 | 126 | ||
| Cash Conversion Cycle | 79 | 71 | -337 | -331 | -233 | -99 | -76 | -133 | -99 | -78 | 52 | 128 |
| Working Capital Days | 65 | 43 | 41 | 27 | 36 | 47 | 35 | 24 | 23 | 17 | 43 | 64 |
| ROCE % | 24% | 25% | 22% | 22% | 23% | 24% | 17% | 15% | 20% | 20% | 22% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Small Cap Fund | 3,300,697 | 4.43 | 524.3 | 3,300,697 | 2025-04-22 17:25:37 | 0% |
| Kotak Small Cap Fund - Regular Plan | 3,018,341 | 3.94 | 479.45 | 3,018,341 | 2025-04-22 17:25:37 | 0% |
| DSP Mid Cap Fund | 2,481,398 | 2.73 | 394.16 | 2,481,398 | 2025-04-22 17:25:37 | 0% |
| Nippon India Small Cap Fund | 2,477,151 | 1.05 | 393.48 | 2,477,151 | 2025-04-22 17:25:37 | 0% |
| Aditya Birla Sun Life Digital India Fund | 1,152,664 | 4.63 | 183.09 | 1,152,664 | 2025-04-22 01:28:26 | 0% |
| ICICI Prudential Smallcap Fund | 1,150,829 | 3.05 | 182.8 | 1,150,829 | 2025-04-22 17:25:37 | 0% |
| Franklin India Smaller Companies Fund | 1,035,911 | 1.7 | 164.55 | 1,035,911 | 2025-04-22 02:06:43 | 0% |
| 360 ONE Focused Equity Fund | 889,117 | 2.89 | 141.23 | 889,117 | 2025-04-22 17:25:37 | 0% |
| ICICI Prudential Multicap Fund | 571,817 | 1.04 | 90.83 | 571,817 | 2025-04-22 17:25:37 | 0% |
| ICICI Prudential Technology Fund | 423,664 | 0.62 | 67.3 | 423,664 | 2025-04-22 17:25:37 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 55.95 | 62.24 | 47.03 | 47.75 | 33.08 |
| Diluted EPS (Rs.) | 55.51 | 61.71 | 46.71 | 47.54 | 33.06 |
| Cash EPS (Rs.) | 82.92 | 87.34 | 69.71 | 64.72 | 50.75 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 478.32 | 410.53 | 313.16 | 282.01 | 268.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 478.32 | 410.53 | 313.16 | 282.01 | 268.49 |
| Revenue From Operations / Share (Rs.) | 663.10 | 643.89 | 543.93 | 410.72 | 375.67 |
| PBDIT / Share (Rs.) | 111.70 | 123.31 | 98.06 | 84.23 | 64.99 |
| PBIT / Share (Rs.) | 87.63 | 99.28 | 74.86 | 66.82 | 47.31 |
| PBT / Share (Rs.) | 79.27 | 82.74 | 61.59 | 63.26 | 43.37 |
| Net Profit / Share (Rs.) | 58.85 | 63.31 | 46.51 | 47.31 | 33.07 |
| NP After MI And SOA / Share (Rs.) | 55.47 | 61.51 | 46.51 | 47.31 | 33.07 |
| PBDIT Margin (%) | 16.84 | 19.15 | 18.02 | 20.50 | 17.29 |
| PBIT Margin (%) | 13.21 | 15.41 | 13.76 | 16.26 | 12.59 |
| PBT Margin (%) | 11.95 | 12.84 | 11.32 | 15.40 | 11.54 |
| Net Profit Margin (%) | 8.87 | 9.83 | 8.55 | 11.51 | 8.80 |
| NP After MI And SOA Margin (%) | 8.36 | 9.55 | 8.55 | 11.51 | 8.80 |
| Return on Networth / Equity (%) | 11.59 | 16.03 | 14.83 | 16.75 | 12.30 |
| Return on Capital Employeed (%) | 15.37 | 20.61 | 18.29 | 20.92 | 15.37 |
| Return On Assets (%) | 8.00 | 9.74 | 7.85 | 10.91 | 8.09 |
| Long Term Debt / Equity (X) | 0.01 | 0.06 | 0.14 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.04 | 0.10 | 0.26 | 0.10 | 0.09 |
| Asset Turnover Ratio (%) | 1.00 | 1.05 | 0.54 | 0.45 | 0.38 |
| Current Ratio (X) | 3.03 | 2.15 | 1.58 | 2.30 | 2.57 |
| Quick Ratio (X) | 2.60 | 1.86 | 1.36 | 2.07 | 2.43 |
| Inventory Turnover Ratio (X) | 2.18 | 2.19 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 53.59 | 44.81 | 51.20 | 56.51 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 37.37 | 32.22 | 34.16 | 41.31 | 0.00 |
| Earning Retention Ratio (%) | 46.41 | 55.19 | 48.80 | 43.49 | 0.00 |
| Cash Earning Retention Ratio (%) | 62.63 | 67.78 | 65.84 | 58.69 | 0.00 |
| Interest Coverage Ratio (X) | 13.36 | 11.80 | 10.85 | 23.66 | 16.51 |
| Interest Coverage Ratio (Post Tax) (X) | 8.04 | 7.64 | 6.61 | 14.29 | 9.40 |
| Enterprise Value (Cr.) | 13380.90 | 21896.86 | 11188.05 | 9314.42 | 5941.90 |
| EV / Net Operating Revenue (X) | 1.82 | 3.06 | 1.86 | 2.05 | 1.44 |
| EV / EBITDA (X) | 10.79 | 16.00 | 10.32 | 10.02 | 8.31 |
| MarketCap / Net Operating Revenue (X) | 1.91 | 3.10 | 1.82 | 2.26 | 1.73 |
| Retention Ratios (%) | 46.40 | 55.18 | 48.79 | 43.48 | 0.00 |
| Price / BV (X) | 2.64 | 5.20 | 3.17 | 3.29 | 2.41 |
| Price / Net Operating Revenue (X) | 1.91 | 3.10 | 1.82 | 2.26 | 1.73 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.05 | 0.05 |
After reviewing the key financial ratios for Cyient Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 55.95. This value is within the healthy range. It has decreased from 62.24 (Mar 24) to 55.95, marking a decrease of 6.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 55.51. This value is within the healthy range. It has decreased from 61.71 (Mar 24) to 55.51, marking a decrease of 6.20.
- For Cash EPS (Rs.), as of Mar 25, the value is 82.92. This value is within the healthy range. It has decreased from 87.34 (Mar 24) to 82.92, marking a decrease of 4.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 478.32. It has increased from 410.53 (Mar 24) to 478.32, marking an increase of 67.79.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 478.32. It has increased from 410.53 (Mar 24) to 478.32, marking an increase of 67.79.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 663.10. It has increased from 643.89 (Mar 24) to 663.10, marking an increase of 19.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 111.70. This value is within the healthy range. It has decreased from 123.31 (Mar 24) to 111.70, marking a decrease of 11.61.
- For PBIT / Share (Rs.), as of Mar 25, the value is 87.63. This value is within the healthy range. It has decreased from 99.28 (Mar 24) to 87.63, marking a decrease of 11.65.
- For PBT / Share (Rs.), as of Mar 25, the value is 79.27. This value is within the healthy range. It has decreased from 82.74 (Mar 24) to 79.27, marking a decrease of 3.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.85. This value is within the healthy range. It has decreased from 63.31 (Mar 24) to 58.85, marking a decrease of 4.46.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 55.47. This value is within the healthy range. It has decreased from 61.51 (Mar 24) to 55.47, marking a decrease of 6.04.
- For PBDIT Margin (%), as of Mar 25, the value is 16.84. This value is within the healthy range. It has decreased from 19.15 (Mar 24) to 16.84, marking a decrease of 2.31.
- For PBIT Margin (%), as of Mar 25, the value is 13.21. This value is within the healthy range. It has decreased from 15.41 (Mar 24) to 13.21, marking a decrease of 2.20.
- For PBT Margin (%), as of Mar 25, the value is 11.95. This value is within the healthy range. It has decreased from 12.84 (Mar 24) to 11.95, marking a decrease of 0.89.
- For Net Profit Margin (%), as of Mar 25, the value is 8.87. This value is within the healthy range. It has decreased from 9.83 (Mar 24) to 8.87, marking a decrease of 0.96.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.36. This value is within the healthy range. It has decreased from 9.55 (Mar 24) to 8.36, marking a decrease of 1.19.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.59. This value is below the healthy minimum of 15. It has decreased from 16.03 (Mar 24) to 11.59, marking a decrease of 4.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.37. This value is within the healthy range. It has decreased from 20.61 (Mar 24) to 15.37, marking a decrease of 5.24.
- For Return On Assets (%), as of Mar 25, the value is 8.00. This value is within the healthy range. It has decreased from 9.74 (Mar 24) to 8.00, marking a decrease of 1.74.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.04, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.00. It has decreased from 1.05 (Mar 24) to 1.00, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 3.03. This value exceeds the healthy maximum of 3. It has increased from 2.15 (Mar 24) to 3.03, marking an increase of 0.88.
- For Quick Ratio (X), as of Mar 25, the value is 2.60. This value exceeds the healthy maximum of 2. It has increased from 1.86 (Mar 24) to 2.60, marking an increase of 0.74.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 4. It has decreased from 2.19 (Mar 24) to 2.18, marking a decrease of 0.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 53.59. This value exceeds the healthy maximum of 50. It has increased from 44.81 (Mar 24) to 53.59, marking an increase of 8.78.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 37.37. This value is within the healthy range. It has increased from 32.22 (Mar 24) to 37.37, marking an increase of 5.15.
- For Earning Retention Ratio (%), as of Mar 25, the value is 46.41. This value is within the healthy range. It has decreased from 55.19 (Mar 24) to 46.41, marking a decrease of 8.78.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 62.63. This value is within the healthy range. It has decreased from 67.78 (Mar 24) to 62.63, marking a decrease of 5.15.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.36. This value is within the healthy range. It has increased from 11.80 (Mar 24) to 13.36, marking an increase of 1.56.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.04. This value is within the healthy range. It has increased from 7.64 (Mar 24) to 8.04, marking an increase of 0.40.
- For Enterprise Value (Cr.), as of Mar 25, the value is 13,380.90. It has decreased from 21,896.86 (Mar 24) to 13,380.90, marking a decrease of 8,515.96.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.82. This value is within the healthy range. It has decreased from 3.06 (Mar 24) to 1.82, marking a decrease of 1.24.
- For EV / EBITDA (X), as of Mar 25, the value is 10.79. This value is within the healthy range. It has decreased from 16.00 (Mar 24) to 10.79, marking a decrease of 5.21.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.91, marking a decrease of 1.19.
- For Retention Ratios (%), as of Mar 25, the value is 46.40. This value is within the healthy range. It has decreased from 55.18 (Mar 24) to 46.40, marking a decrease of 8.78.
- For Price / BV (X), as of Mar 25, the value is 2.64. This value is within the healthy range. It has decreased from 5.20 (Mar 24) to 2.64, marking a decrease of 2.56.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.91, marking a decrease of 1.19.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cyient Ltd:
- Net Profit Margin: 8.87%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.37% (Industry Average ROCE: 14.93%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.59% (Industry Average ROE: 20.42%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.04
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.6
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.1 (Industry average Stock P/E: 91.41)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.04
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.87%
Fundamental Analysis of Cyient Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 4th Floor, �A� Wing, 11, Software Units Layout, Hyderabad Telangana 500081 | company.secretary@cyient.com http://www.cyient.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. B V R Mohan Reddy | Founder & Executive Chairman |
| Mr. M M Murugappan | Non Executive Chairman |
| Mr. Krishna Bodanapu | Managing Director & CEO |
| Mr. Karthikeyan Natarajan | COO & Executive Director |
| Mr. Ajay Aggarwal | Executive Director & CFO |
| Mr. Alain De Taeye | Non Executive Director |
| Ms. Matangi Gowrishankar | Independent Director |
| Mr. Vikas Sehgal | Independent Director |
| Mr. Vinai Thummalapally | Independent Director |
| Mr. Vivek Narayan Gouir | Independent Director |
| Mr. Ramesh Abhishek | Independent Director |
Cyient Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹1,755.00 |
| Previous Day | ₹1,777.80 |
FAQ
What is the intrinsic value of Cyient Ltd?
Cyient Ltd's intrinsic value (as of 25 November 2025) is 1160.09 which is 3.58% higher the current market price of 1,120.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 12,451 Cr. market cap, FY2025-2026 high/low of 2,112/1,050, reserves of ₹5,509 Cr, and liabilities of 7,922 Cr.
What is the Market Cap of Cyient Ltd?
The Market Cap of Cyient Ltd is 12,451 Cr..
What is the current Stock Price of Cyient Ltd as on 25 November 2025?
The current stock price of Cyient Ltd as on 25 November 2025 is 1,120.
What is the High / Low of Cyient Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cyient Ltd stocks is 2,112/1,050.
What is the Stock P/E of Cyient Ltd?
The Stock P/E of Cyient Ltd is 22.1.
What is the Book Value of Cyient Ltd?
The Book Value of Cyient Ltd is 501.
What is the Dividend Yield of Cyient Ltd?
The Dividend Yield of Cyient Ltd is 2.32 %.
What is the ROCE of Cyient Ltd?
The ROCE of Cyient Ltd is 16.6 %.
What is the ROE of Cyient Ltd?
The ROE of Cyient Ltd is 12.8 %.
What is the Face Value of Cyient Ltd?
The Face Value of Cyient Ltd is 5.00.